Combigene (Sweden) Price History
COMBI Stock | SEK 2.64 0.04 1.49% |
If you're considering investing in Combigene Stock, it is important to understand the factors that can impact its price. As of today, the current price of Combigene stands at 2.64, as last reported on the 30th of November, with the highest price reaching 2.78 and the lowest price hitting 2.54 during the day. Combigene appears to be dangerous, given 3 months investment horizon. Combigene AB secures Sharpe Ratio (or Efficiency) of 0.0275, which signifies that the company had a 0.0275% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Combigene AB, which you can use to evaluate the volatility of the firm. Please makes use of Combigene's Risk Adjusted Performance of 0.0267, downside deviation of 6.7, and Mean Deviation of 4.28 to double-check if our risk estimates are consistent with your expectations.
Combigene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Combigene |
Sharpe Ratio = 0.0275
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | COMBI | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.87 actual daily | 70 70% of assets are less volatile |
Expected Return
0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Combigene is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Combigene by adding it to a well-diversified portfolio.
Combigene Stock Price History Chart
There are several ways to analyze Combigene Stock price data. The simplest method is using a basic Combigene candlestick price chart, which shows Combigene price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 30, 2024 | 2.8 |
Lowest Price | October 31, 2024 | 1.47 |
Combigene November 30, 2024 Stock Price Synopsis
Various analyses of Combigene's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Combigene Stock. It can be used to describe the percentage change in the price of Combigene from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Combigene Stock.Combigene Accumulation Distribution | 1,872 | |
Combigene Price Daily Balance Of Power | (0.17) | |
Combigene Price Rate Of Daily Change | 0.99 | |
Combigene Price Action Indicator | (0.04) |
Combigene November 30, 2024 Stock Price Analysis
Combigene Stock Price History Data
The price series of Combigene for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 1.35 with a coefficient of variation of 10.13. The prices are distributed with arithmetic mean of 2.5. The median price for the last 90 days is 2.54. The company had 1:20 stock split on 7th of June 2021.Open | High | Low | Close | Volume | ||
11/29/2024 | 2.54 | 2.78 | 2.54 | 2.64 | 21,685 | |
11/28/2024 | 2.46 | 2.64 | 2.46 | 2.64 | 41,612 | |
11/27/2024 | 2.38 | 2.68 | 2.38 | 2.68 | 14,054 | |
11/26/2024 | 2.48 | 2.56 | 2.36 | 2.56 | 43,362 | |
11/25/2024 | 2.56 | 2.62 | 2.36 | 2.36 | 24,140 | |
11/22/2024 | 2.58 | 2.60 | 2.56 | 2.56 | 3,189 | |
11/21/2024 | 2.46 | 2.62 | 2.46 | 2.58 | 13,133 | |
11/20/2024 | 2.56 | 2.60 | 2.48 | 2.48 | 10,356 | |
11/19/2024 | 2.58 | 2.68 | 2.50 | 2.56 | 17,624 | |
11/18/2024 | 2.60 | 2.66 | 2.54 | 2.62 | 14,774 | |
11/15/2024 | 2.80 | 2.86 | 2.64 | 2.80 | 5,955 | |
11/14/2024 | 2.38 | 2.76 | 2.38 | 2.74 | 48,775 | |
11/13/2024 | 2.48 | 2.58 | 2.34 | 2.58 | 51,403 | |
11/12/2024 | 2.60 | 2.60 | 2.46 | 2.58 | 21,194 | |
11/11/2024 | 2.50 | 2.64 | 2.40 | 2.40 | 5,020 | |
11/08/2024 | 2.54 | 2.66 | 2.24 | 2.66 | 52,055 | |
11/07/2024 | 2.54 | 2.66 | 2.54 | 2.66 | 9,581 | |
11/06/2024 | 2.60 | 2.82 | 2.50 | 2.66 | 32,701 | |
11/05/2024 | 2.58 | 2.88 | 2.50 | 2.56 | 94,476 | |
11/04/2024 | 2.22 | 2.88 | 2.10 | 2.50 | 138,554 | |
11/01/2024 | 1.49 | 2.38 | 1.49 | 2.08 | 623,121 | |
10/31/2024 | 1.63 | 1.78 | 1.27 | 1.47 | 261,840 | |
10/30/2024 | 1.61 | 1.80 | 1.61 | 1.69 | 214,924 | |
10/29/2024 | 1.71 | 1.85 | 1.63 | 1.76 | 181,711 | |
10/28/2024 | 2.26 | 2.26 | 1.58 | 1.72 | 885,885 | |
10/25/2024 | 2.52 | 2.52 | 2.30 | 2.32 | 113,114 | |
10/24/2024 | 2.44 | 2.96 | 2.34 | 2.50 | 19,344 | |
10/23/2024 | 2.44 | 2.70 | 2.44 | 2.44 | 76,593 | |
10/22/2024 | 2.38 | 2.40 | 2.32 | 2.34 | 9,554 | |
10/21/2024 | 2.46 | 2.46 | 2.38 | 2.38 | 7,705 | |
10/18/2024 | 2.50 | 2.50 | 2.42 | 2.46 | 4,751 | |
10/17/2024 | 2.50 | 2.54 | 2.42 | 2.44 | 4,190 | |
10/16/2024 | 2.54 | 2.56 | 2.28 | 2.50 | 48,172 | |
10/15/2024 | 2.54 | 2.56 | 2.38 | 2.42 | 36,672 | |
10/14/2024 | 2.66 | 2.66 | 2.44 | 2.54 | 11,044 | |
10/11/2024 | 2.40 | 2.66 | 2.40 | 2.66 | 25,226 | |
10/10/2024 | 2.36 | 2.64 | 2.36 | 2.64 | 19,736 | |
10/09/2024 | 2.70 | 2.70 | 2.42 | 2.50 | 8,631 | |
10/08/2024 | 2.48 | 2.54 | 2.32 | 2.48 | 19,450 | |
10/07/2024 | 2.50 | 2.88 | 2.42 | 2.58 | 7,127 | |
10/04/2024 | 2.66 | 2.72 | 2.42 | 2.54 | 26,097 | |
10/03/2024 | 2.66 | 2.76 | 2.54 | 2.54 | 17,245 | |
10/02/2024 | 2.72 | 2.78 | 2.64 | 2.66 | 20,501 | |
10/01/2024 | 2.72 | 2.96 | 2.60 | 2.68 | 71,782 | |
09/30/2024 | 2.44 | 3.00 | 2.38 | 2.80 | 73,167 | |
09/27/2024 | 2.44 | 2.46 | 2.28 | 2.44 | 17,569 | |
09/26/2024 | 2.40 | 2.44 | 2.40 | 2.44 | 11,509 | |
09/25/2024 | 2.28 | 2.52 | 2.28 | 2.44 | 4,260 | |
09/24/2024 | 2.46 | 2.46 | 2.36 | 2.44 | 8,976 | |
09/23/2024 | 2.50 | 2.50 | 2.40 | 2.46 | 4,921 | |
09/20/2024 | 2.52 | 2.52 | 2.42 | 2.52 | 2,793 | |
09/19/2024 | 2.52 | 2.54 | 2.46 | 2.46 | 19,208 | |
09/18/2024 | 2.40 | 2.52 | 2.40 | 2.40 | 19,237 | |
09/17/2024 | 2.40 | 2.48 | 2.36 | 2.48 | 15,939 | |
09/16/2024 | 2.42 | 2.46 | 2.34 | 2.46 | 60,688 | |
09/13/2024 | 2.50 | 2.54 | 2.42 | 2.50 | 10,934 | |
09/12/2024 | 2.54 | 2.54 | 2.42 | 2.48 | 49,539 | |
09/11/2024 | 2.76 | 2.76 | 2.44 | 2.52 | 36,115 | |
09/10/2024 | 2.44 | 2.74 | 2.44 | 2.66 | 25,525 | |
09/09/2024 | 2.66 | 2.66 | 2.46 | 2.66 | 21,703 | |
09/06/2024 | 2.72 | 2.74 | 2.62 | 2.66 | 3,195 |
About Combigene Stock history
Combigene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Combigene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Combigene AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Combigene stock prices may prove useful in developing a viable investing in Combigene
CombiGene AB engages in the development and commercialization of gene therapy for the treatment of neurological and psychiatric disorders. CombiGene AB was founded in 1999 and is headquartered in Lund, Sweden. Combigene operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people.
Combigene Stock Technical Analysis
Combigene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Combigene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Combigene's price direction in advance. Along with the technical and fundamental analysis of Combigene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Combigene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0267 | |||
Jensen Alpha | 0.13 | |||
Total Risk Alpha | (1.13) | |||
Sortino Ratio | 0.0065 | |||
Treynor Ratio | 0.5333 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Combigene Stock Analysis
When running Combigene's price analysis, check to measure Combigene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Combigene is operating at the current time. Most of Combigene's value examination focuses on studying past and present price action to predict the probability of Combigene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Combigene's price. Additionally, you may evaluate how the addition of Combigene to your portfolios can decrease your overall portfolio volatility.